首页> 外文期刊>Research in Agriculture, Livestock and Fisheries >Comparative efficacy of BAU-fowl cholera and DLS-fowl cholera vaccines in indigenous chicken
【24h】

Comparative efficacy of BAU-fowl cholera and DLS-fowl cholera vaccines in indigenous chicken

机译:BAU禽霍乱疫苗和DLS禽霍乱疫苗在本地鸡中的比较功效

获取原文
       

摘要

The present study was conducted to determine the immune response induced in indigenous chicken produced against BAU-FC and DLS-FC vaccines with their efficacy study against Pasteurella multocida. A total of forty (40) chickens were selected and divided into Group A (15), Group B (15) and Group C (10). Group A and B were vaccinated with BAU-FCV and DLS-FCV, respectively at the dose rate of 0.5 ml through SC at six weeks of age followed by boostering at 10 weeks of age while Group C was kept as unvaccinated control. Sera samples were collected after primary and booster vaccination and antibody titre was determined by Passive hemagglutination (PHA) test. The mean PHA titres recorded at 4 weeks after primary vaccination was 51.20 ± 7.84 in birds of group A and 38.40 ± 6.40 in birds of Group B. After booster vaccination, mean PHA titer was found 140.80 ± 31.35 at 16 weeks of age in case of BAU-FC vaccinated group and 115.20 ± 12.80 in case of DLS-FC vaccinated group. The mean PHA titer was 204.80 ± 31.35 and 179.20 ± 31.35 at 19 weeks of age in birds of BAU-FC and DLS-FC vaccinated group, respectively. Birds of all groups were challenged with virulent P. multocida at 17 weeks of age. It was observed that vaccinated chickens showed maximal resistance (100%) following challenge with virulent whereas unvaccinated control birds failed to resist the challenge infection. It can be assumed from the findings of present research work that both BAU-FCV and DLS-FCV are able to protect indigenous chicken from the outbreak of avian pasteurellosis and BAU-FV vaccine showed relatively higher immuno-protective titre than that of DLS-FC vaccine. Res. Agric., Livest. Fish.5(2): 193-199, August 2018.
机译:本研究旨在确定在生产的本地鸡中针对BAU-FC和DLS-FC疫苗产生的免疫应答,并针对多杀性巴斯德氏菌进行功效研究。总共选择四十(40)只鸡,并分为A组(15),B组(15)和C组(10)。 A组和B组分别在6周龄时通过SC分别以0.5 ml剂量的BAU-FCV和DLS-FCV接种疫苗,然后在10周龄时加强免疫,而C组作为未接种的对照组。初次和加强免疫后收集血清样品,并通过被动血凝(PHA)测试确定抗体滴度。初次接种疫苗后4周,A组鸟的平均PHA滴度为51.20±7.84,B组鸟为38.40±6.40。加强免疫后,在16周龄时,PHA的平均滴度为140.80±31.35。 BAU-FC疫苗接种组和DLS-FC疫苗接种组为115.20±12.80。在BAU-FC和DLS-FC接种组中,19周龄时的PHA平均滴度分别为204.80±31.35和179.20±31.35。在17周龄时,所有组的鸟类都受到了毒性的多杀性巴氏杆菌的攻击。观察到,用强力攻击后,接种疫苗的鸡表现出最大的抵抗力(100%),而未接种疫苗的对照鸡无法抵抗攻击感染。从当前研究工作的发现可以推测,BAU-FCV和DLS-FCV都能够保护本土鸡免于禽巴氏杆菌病的爆发,并且BAU-FV疫苗的免疫保护滴度比DLS-FC高疫苗。 Res。 Agric。,Livest。 Fish.5(2):193-199,2018年8月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号